| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.4 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |